Cargando…
Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure
Autores principales: | Bartunek, Jozef, Terzic, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Texas Heart® Institute, Houston
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658137/ https://www.ncbi.nlm.nih.gov/pubmed/37881036 http://dx.doi.org/10.14503/THIJ-23-8247 |
Ejemplares similares
-
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015) -
Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021) -
Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
por: Bartunek, Jozef, et al.
Publicado: (2020) -
The CardiAMP Cell Therapy for Heart Failure trial
por: Pepine, Carl J., et al.
Publicado: (2023) -
Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction
por: Segar, Matthew W., et al.
Publicado: (2023)